Skip to content
Schedule a demo
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Waitemata District Health Board

InstitutionResearch output, impact & collaborations

Waitemata District Health Board is a institution indexed in PICO Portal from OpenAlex.

What is known about Waitemata District Health Board?

PICO Portalrecord summary

Waitemata District Health Board is a research organisation in Auckland, NZ. OpenAlex records 1,537 works and 48,890 citations for it. 469 researchers list it as their most recent affiliation.

How many works does Waitemata District Health Board have?

PICO Portalindexed works

Waitemata District Health Board has 1,537 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Waitemata District Health Board have?

PICO Portalcitation count

Waitemata District Health Board has 48,890 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Waitemata District Health Board?

PICO Portalresearcher count

Waitemata District Health Board has 469 researchers in the PICO Portal index.

What is the average h-index at Waitemata District Health Board?

PICO Portalavg h-index

Waitemata District Health Board has an average h-index of 8.5 in OpenAlex.

What is the ROR of Waitemata District Health Board?

PICO Portalror

The ROR for Waitemata District Health Board is on the source record.

What is the OpenAlex record for Waitemata District Health Board?

PICO Portalopenalex

The OpenAlex for Waitemata District Health Board is on the source record.

Who are the most-cited researchers behind Waitemata District Health Board?

PICO Portaltop researchers by citations
1
Marius van Rijnsoever · Colorectal Cancer Treatments and Studies
23 works772 citations
2
Michael Booth · Gallbladder and Bile Duct Disorders
36 works423 citations

What are the most-cited papers on Waitemata District Health Board?

PICO Portalmost cited works
CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer.
Marius van Rijnsoever, Hany Elsaleh, David Joseph, Kieran McCaul, Barry Iacopetta
PubMed. 2003268 Citations
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
Marius van Rijnsoever, F Grieu, H Elsaleh, D Joseph, B Iacopetta
Gut. 2002259 CitationsOPEN ACCESS
The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects
Quoc-Chuong Bui, Michael J. Lieber, H. Rodney Withers, Kevan Corson, Marius van Rijnsoever, Hany Elsaleh
International Journal of Radiation Oncology*Biology*Physics. 2004116 Citations
British Society of Gastroenterology guidelines for oesophageal manometry and oesophageal reflux monitoring
Nigel Trudgill, Daniel Sifrim, Rami Sweis, Mark Fullard, Kumar Basu, Mimi McCord, Michael Booth, John Hayman, Guy E. Boeckxstaens, Brian T. Johnston, Nicola Ager, John de Caestecker
Gut. 201991 CitationsOPEN ACCESS
Major abdominal surgery in octogenarians.
Saleh Abbas, Michael Booth
PubMed. 200371 Citations

How much of the research on Waitemata District Health Board is open access?

PICO Portalopen access share
33%OPEN ACCESS
Gold
8%
Green
0%
Hybrid
8%
Bronze
17%
Closed
67%

Related on PICO Portal

Global Cancer Incidence and Screening
Top Topic
Cardiac Imaging and Diagnostics
Top Topic
Schizophrenia research and treatment
Top Topic
Frailty in Older Adults
Top Topic
Healthcare Decision-Making and Restraints
Top Topic
Colorectal Cancer Screening and Detection
Top Topic
470M+ articles · 14-day free trial